US Broker Ratings

Nutex Health Inc. (NUTX) Stock Analysis: A Potential 124% Upside in the Healthcare Sector

Nutex Health Inc. (NUTX), a Houston-based healthcare service provider, has captured investor attention with its significant potential upside. The company, operating in the thriving healthcare sector,..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating the Challenges and Opportunities in Healthcare Devices

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector, operates in the medical devices industry with a focus on innovative solutions that target..

Cullinan Therapeutics, Inc. (CGEM): Investor Outlook with a Potential Upside of 245.88%

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a burgeoning entity in the biotechnology sector, has recently caught the attention of investors, offering a staggering potential upside of 245.88%...

Upstream Bio, Inc. (UPB) Stock Analysis: A 349.88% Potential Upside in the Biotech Arena

Upstream Bio, Inc. (UPB) is emerging as a compelling prospect for investors seeking opportunities in the healthcare sector, specifically within biotechnology. Despite its current challenges, the..

Opthea Limited (OPT) Stock Analysis: Navigating Challenges in Biotech with a $524.82 Million Market Cap

Opthea Limited (ASX: OPT), an Australian biotechnology firm, stands at the forefront of the healthcare sector with its innovative approach to treating eye diseases. With a..

Sana Biotechnology (SANA) Stock Analysis: A Look at Its 109.74% Potential Upside in the Biotech Sector

Sana Biotechnology, Inc. (NASDAQ: SANA) is drawing attention in the biotechnology sector for its ambitious approach to developing engineered cells as medicines. With a market capitalization..

Arvinas, Inc. (ARVN) Stock Analysis: A Biotech Innovator with a 149.50% Potential Upside

Arvinas, Inc. (NASDAQ: ARVN), a pioneering biotechnology company, is attracting significant interest from investors, driven by its innovative approach to disease treatment and the potential for..

OrthoPediatrics Corp. (KIDS) Stock Analysis: 60.83% Potential Upside in the Pediatric Orthopedic Market

OrthoPediatrics Corp. (NASDAQ: KIDS) is a unique player in the healthcare sector, specializing in medical devices tailored for pediatric orthopedic conditions. With a market capitalization of..

Orthofix Medical Inc. (OFIX) Stock Analysis: Unpacking a 105% Potential Upside for Investors

Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the healthcare sector with a focus on medical devices, is capturing investor attention with its substantial potential..

RxSight, Inc. (RXST) Stock Analysis: Eyeing a Potential 187% Upside with Innovative Medical Devices

RxSight, Inc. (NASDAQ: RXST), a pioneering name in the medical devices industry, is capturing investor attention with its robust potential upside and innovative solutions in the..

Evolus, Inc. (EOLS) Stock Analysis: A 152% Potential Upside with Strong Buy Ratings

Evolus, Inc. (NASDAQ: EOLS) is catching the eye of investors with a remarkable potential upside of 152.37%, positioning it as a compelling choice in the healthcare..

Cogent Biosciences, Inc. (COGT): Investor Outlook on a Biotech with a Potential 32.79% Upside

Cogent Biosciences, Inc. (NASDAQ: COGT) has been capturing the attention of investors in the biotechnology sector, thanks to its strategic focus on precision therapies targeting genetically..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Exploring a Potential 77.77% Upside in CNS Therapeutics

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a dynamic player in the biotechnology sector, is gaining attention with its ambitious pipeline focused on therapies for central nervous..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A 90% Upside Potential in the Healthcare Sector

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a key player in the biopharmaceutical landscape, stands out with an impressive potential upside of 90.72% according to current analyst ratings...

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a Promising 226.78% Upside in Biotechnology

Bicycle Therapeutics plc (NASDAQ: BCYC) is capturing the attention of investors with its ambitious pipeline and a notable potential upside of 226.78%, according to analyst ratings...

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Biotechnology Pioneer with 210% Upside Potential

Anavex Life Sciences Corp. (NASDAQ: AVXL) is making waves in the biotechnology sector, capturing the attention of investors with a potential upside of 210.43%. With a..

Nurix Therapeutics, Inc. (NRIX): Biotechnology Innovator with a Promising 150.90% Potential Upside

Nurix Therapeutics, Inc. (NASDAQ: NRIX), an innovative player in the biotechnology industry, is currently captivating investor interest with a significant potential upside of 150.90%. As a..

Weave Communications, Inc. (WEAV) Investor Outlook: Eyeing an 87% Upside with Innovative Healthcare Solutions

Weave Communications, Inc. (NYSE: WEAV) stands at the forefront of transforming healthcare communications with its robust software platform tailored for small and medium-sized healthcare businesses. While..

Auna SA (AUNA) Stock Analysis: Strong Buy Consensus with Nearly 97% Upside Potential

For investors on the lookout for opportunities in the healthcare sector, Auna SA (AUNA) presents an intriguing proposition. Operating within the medical care facilities industry, Auna..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: A 177% Potential Upside in the Biotechnology Sector

Tyra Biosciences, Inc. (NASDAQ: TYRA) has captured the attention of investors due to its promising pipeline of precision medicines targeting fibroblast growth factor receptor (FGFR) biology...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds